Manipal Health Enterprises shares fell sharply on Thursday day after their strong market debut, triggering profit booking. Analysts remain constructive on the company’s long-term prospects but advise fresh investors to wait for better entry levels, citing premium valuations, while allotted investors can continue holding with a stop-loss at Rs 620.
Ace investor Madhusudan Kela cuts stake in this multibagger stock after 200% rally in a year. Do you own?
Ace investor Madhusudan Kela’s family reduced its stake in Rashi Peripherals during the June quarter after the stock surged nearly 200% over the past year.